This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sirnaomics, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Alan Lu: Innovator in RNAi Therapeutics
Introduction
Alan Lu is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of RNA interference (RNAi) therapeutics, particularly in the context of viral infections. His work focuses on developing innovative solutions for the treatment of severe acute respiratory infections, including those caused by the novel coronavirus.
Latest Patents
Alan Lu holds a patent for a groundbreaking invention titled "Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV)." This patent outlines compositions and methods for the development of potent siRNA therapeutics aimed at preventing and treating COVID-19 infections. The pharmaceutical compositions include siRNA cocktails that target critical viral genes, utilizing both polymeric nanoparticle carriers and liposomal nanoparticle carriers. The patent also details various administration methods, such as airway instillation, subcutaneous injections, and nebulizer aerosolization.
Career Highlights
Alan Lu is associated with Sirnaomics, Inc., a company dedicated to advancing RNAi therapeutics. His work at the company has positioned him as a key player in the fight against viral infections, particularly in the wake of the COVID-19 pandemic. His innovative approaches have garnered attention in the scientific community and have the potential to impact public health significantly.
Collaborations
Alan Lu collaborates with notable colleagues, including Danny Tang and Xueping Chen. Their combined expertise enhances the research and development efforts at Sirnaomics, Inc., fostering an environment of innovation and discovery.
Conclusion
Alan Lu's contributions to RNAi therapeutics exemplify the vital role of inventors in addressing global health challenges. His patent for COVID-19 treatment methods showcases his commitment to advancing medical science and improving patient outcomes.